BiotechTubeBiotechTube
Home/Chemogenics BioPharma/Francis X. Tavares, Ph.D.
FX

Francis X. Tavares, Ph.D.

Founder / CEO

Chemogenics BioPharma

Therapeutic Areas

Metabolic DiseaseOncologyInflammationImmunologyCardiovascular Diseases

Chemogenics BioPharma Pipeline

DrugIndicationPhase
TrilaciclibChemotherapy-induced myelosuppressionApproved/Commercial
Lerociclib (Lerocliclib)Breast CancerPhase 3